Carbohydrate Metabolism Practice Questions

Q: A baby presents with early morning hypoglycemia. Glucagon administration raises blood glucose levels if given after meals but not during fasting. Liver biopsy shows increased glycogen deposits. What enzyme defect is most likely responsible?

Debranching enzyme. ### Explanation The clinical presentation describes **Cori disease (Type III Glycogen Storage Disease)**, caused by a deficiency of the **Debranching enzyme** (Amylo-1,6-glucosidase). **1. Why Debranching Enzyme is correct:** In Cori disease, glycogenolysis is impaired because the debranching enzyme cannot remove the "limit dextrins" (short branches). * **Post-prandial state:** Glucagon raises blood glucose because the phosphorylase enzyme can still act on the outer linear chains of newly synthesized glycogen. * **Fasting state:** Once the outer chains are exhausted, phosphorylase stops at the branch points. Since the debranching enzyme is missing, no further glucose can be released, leading to **fasting hypoglycemia** and the accumulation of **limit dextrin-like glycogen** in the liver. **2. Analysis of Incorrect Options:** * **A. Muscle phosphorylase (McArdle Disease/Type V):** Affects muscles only. It presents with exercise intolerance and cramps, not fasting hypoglycemia or hepatomegaly. * **B. Glucose-6-phosphatase (Von Gierke Disease/Type I):** This is the most severe GSD. Glucagon administration **never** raises blood glucose (even after meals) because the final step of glucose release is blocked. It is also associated with severe lactic acidosis and hyperuricemia. * **C. Branching enzyme (Andersen Disease/Type IV):** Presents with "amylopectin-like" glycogen (long, unbranched chains). It typically leads to early liver cirrhosis and failure, rather than isolated hypoglycemia. **3. High-Yield Clinical Pearls for NEET-PG:** * **Cori vs. Von Gierke:** Both have hepatomegaly and hypoglycemia, but Cori is **milder**, has **normal lactate** levels, and responds to glucagon in the fed state. * **Limit Dextrin:** The hallmark biochemical finding in Cori disease. * **Treatment:** Frequent high-protein meals (protein can be converted to glucose via gluconeogenesis, which remains intact in Cori disease).

Q: A patient has a rare disease characterized by impaired secretory function of the alpha-cells of the pancreas. Direct stimulation of which of the following pathways in the liver will be impaired?

Gluconeogenesis. **Explanation** The core of this question lies in understanding the hormonal regulation of hepatic metabolism. **Why Gluconeogenesis is Correct:** The alpha-cells of the pancreas are responsible for secreting **Glucagon**. Glucagon is a "counter-regulatory" hormone released during fasting states. Its primary role in the liver is to maintain blood glucose levels by stimulating **Gluconeogenesis** (the synthesis of glucose from non-carbohydrate precursors) and Glycogenolysis. It achieves this by increasing cAMP levels, activating Protein Kinase A, and inducing key enzymes like PEPCK and Fructose-1,6-bisphosphatase. If alpha-cell function is impaired, glucagon levels drop, leading to a failure in the direct stimulation of the gluconeogenic pathway. **Why the other options are incorrect:** * **Glycogenesis & Glycolysis:** These pathways are stimulated by **Insulin** (secreted by beta-cells), not glucagon. Glucagon actually *inhibits* glycolysis (by decreasing Fructose-2,6-bisphosphate) and glycogenesis to prevent a futile cycle during fasting. * **Citric Acid Cycle (TCA):** While glucagon influences substrate availability for the TCA cycle, it does not "directly stimulate" the cycle as a primary metabolic pathway in the same regulatory manner as gluconeogenesis. **NEET-PG High-Yield Pearls:** * **Glucagon’s Second Messenger:** It acts via the **Gαs - Adenylate Cyclase - cAMP** pathway. * **Key Regulatory Enzyme:** Glucagon inhibits **Pyruvate Kinase** via phosphorylation, diverting phosphoenolpyruvate (PEP) toward gluconeogenesis instead of glycolysis. * **Clinical Correlation:** Patients with glucagon deficiency (or alpha-cell failure) are highly prone to **fasting hypoglycemia**. * **Insulin/Glucagon Ratio:** It is the ratio of these two hormones, rather than absolute levels, that dictates the direction of hepatic metabolic flux.

Q: Which of the following enzymes is involved in gluconeogenesis, except?

Phosphoglucomutase. ### Explanation **Gluconeogenesis** is the metabolic pathway that results in the generation of glucose from non-carbohydrate precursors. It essentially reverses glycolysis but must bypass three irreversible steps using four unique enzymes. #### Why Phosphoglucomutase is the Correct Answer **Phosphoglucomutase** is an enzyme involved in **glycogenesis** and **glycogenolysis**. It catalyzes the reversible conversion of Glucose-1-Phosphate to Glucose-6-Phosphate. While it handles glucose derivatives, it is not a component of the gluconeogenic pathway, which focuses on converting pyruvate/lactate/amino acids into glucose. #### Analysis of Other Options * **Pyruvate Carboxylase (Option D):** This is the first regulatory enzyme of gluconeogenesis. It converts pyruvate to oxaloacetate in the mitochondria (requires Biotin and ATP). * **Fructose 1,6-bisphosphatase (Option B):** This is the **rate-limiting enzyme** of gluconeogenesis. It bypasses the irreversible PFK-1 step of glycolysis by converting Fructose 1,6-bisphosphate to Fructose 6-phosphate. * **Phosphoglycerate Kinase (Option A):** This enzyme catalyzes a **reversible** step in glycolysis. Because it is reversible, the same enzyme is utilized in gluconeogenesis to convert 1,3-bisphosphoglycerate to 3-phosphoglycerate (and vice versa). #### NEET-PG High-Yield Pearls * **The Four Key Gluconeogenic Enzymes:** 1. Pyruvate Carboxylase 2. PEP Carboxykinase (PEPCK) 3. Fructose 1,6-bisphosphatase (Rate-limiting) 4. Glucose 6-phosphatase (Absent in muscle, hence muscle cannot contribute to blood glucose). * **Location:** Gluconeogenesis occurs primarily in the **Liver** (90%) and Kidney (10%). * **Subcellular site:** It is a "mixed" pathway; Pyruvate carboxylase is **mitochondrial**, while the rest are **cytosolic** (except Glucose 6-phosphatase, which is in the ER).

Q: Which metabolite is involved in glycolysis, the HMP shunt pathway, and gluconeogenesis?

Glucose-6-phosphate. **Explanation:** **Glucose-6-phosphate (G6P)** is the central metabolic hub of carbohydrate metabolism, acting as a common intermediate for several intersecting pathways. 1. **Glycolysis:** G6P is the first intermediate formed after glucose enters the cell (catalyzed by Hexokinase/Glucokinase). It is then isomerized to Fructose-6-phosphate. 2. **HMP Shunt (Pentose Phosphate Pathway):** G6P is the starting substrate for this pathway. It is oxidized by **G6P Dehydrogenase (G6PD)** to generate NADPH and ribose-5-phosphate. 3. **Gluconeogenesis:** It is the final intermediate produced before the release of free glucose. The enzyme **Glucose-6-phosphatase** (found in the liver and kidney) removes the phosphate group to allow glucose to enter the bloodstream. 4. **Glycogenesis/Glycogenolysis:** It also serves as the link to glycogen metabolism via conversion to Glucose-1-phosphate. **Analysis of Incorrect Options:** * **A. Glucose-1-phosphate:** Primarily involved in Glycogenesis and Glycogenolysis; it is not a direct intermediate of glycolysis or the HMP shunt. * **C. Fructose-6-phosphate:** While involved in glycolysis and gluconeogenesis, it is not the starting substrate for the HMP shunt (though it can be a recycling product). * **D. Pyruvate:** The end product of aerobic glycolysis and a substrate for gluconeogenesis, but it plays no role in the HMP shunt. **NEET-PG High-Yield Pearls:** * **G6PD Deficiency:** The most common enzyme deficiency worldwide, leading to hemolytic anemia due to the inability of RBCs to generate NADPH via the HMP shunt. * **Von Gierke Disease (GSD Type I):** Caused by a deficiency of **Glucose-6-phosphatase**, leading to severe fasting hypoglycemia and hepatomegaly because G6P cannot be converted back to glucose. * **Muscle Metabolism:** Muscle lacks Glucose-6-phosphatase; therefore, muscle glycogen cannot contribute to blood glucose levels.

Q: What are isomers that differ in the position of -H and -OH at the 2nd, 3rd, and 4th carbon atoms of glucose called?

Epimers. ### Explanation **1. Why Epimers is the Correct Answer:** Epimers are a subtype of diastereomers that differ in configuration around only **one specific chiral carbon atom** (other than the anomeric carbon). Glucose, mannose, and galactose are the most clinically relevant examples: * **C-2 Epimer:** Glucose and **Mannose** differ only at the 2nd carbon. * **C-4 Epimer:** Glucose and **Galactose** differ only at the 4th carbon. * **C-3 Epimer:** Glucose and **Allose** (though less clinically common) differ at the 3rd carbon. Since the question refers to isomers differing at these specific positions (2nd, 3rd, or 4th), they are classified as epimers. **2. Why Other Options are Incorrect:** * **Optical Isomers:** This is a broad term for compounds that rotate plane-polarized light (dextrorotatory or levorotatory). While epimers are optical isomers, the term is too general and does not specifically describe the positional difference at a single carbon. * **Anomers:** These are isomers that differ specifically at the **anomeric carbon** (C-1 for glucose, C-2 for fructose) during ring closure, resulting in $\alpha$ and $\beta$ forms. * **D,L Isomers (Enantiomers):** These are non-superimposable mirror images. They differ at **all** chiral centers, determined by the orientation of the -OH group on the most distant chiral carbon from the carbonyl group (C-5 in glucose). **3. NEET-PG Clinical Pearls & High-Yield Facts:** * **Enzyme Fact:** The interconversion of epimers (e.g., Galactose to Glucose) is catalyzed by **Epimerases** (e.g., UDP-galactose 4-epimerase). * **Mnemonic:** **"Ga-4-G"** (Galactose is the C-4 epimer of Glucose) and **"Ma-2-G"** (Mannose is the C-2 epimer of Glucose). * **Clinical Link:** Classic Galactosemia involves a deficiency in GALT, but the body can still synthesize galactose for glycolipids via the 4-epimerase enzyme.

Q: Which enzyme of glycolysis is also used in gluconeogenesis?

Phosphotriose isomerase. **Explanation:** The metabolic pathways of **Glycolysis** and **Gluconeogenesis** share several enzymes; however, they differ at three specific "irreversible" steps. **Why the correct answer is right:** **Phosphotriose isomerase** (also known as Triose Phosphate Isomerase) is a **reversible** enzyme. In glycolysis, it interconverts Dihydroxyacetone phosphate (DHAP) and Glyceraldehyde-3-phosphate (G3P). Because this reaction is near equilibrium, the same enzyme is utilized in gluconeogenesis to facilitate the reverse reaction. All reversible steps of glycolysis are shared with the gluconeogenic pathway. **Why the incorrect options are wrong:** Options A, B, and C represent the **three irreversible "bottleneck" steps** of glycolysis. These steps have high negative Gibbs free energy and must be bypassed in gluconeogenesis by different, specific enzymes: * **Glucokinase (A):** Bypassed by *Glucose-6-phosphatase* in gluconeogenesis. * **Phosphofructokinase-1 (B):** The rate-limiting step of glycolysis, bypassed by *Fructose-1,6-bisphosphatase*. * **Pyruvate kinase (C):** Bypassed by a two-step process involving *Pyruvate carboxylase* and *PEP carboxykinase (PEPCK)*. **High-Yield Clinical Pearls for NEET-PG:** * **Location:** Gluconeogenesis occurs mainly in the **Liver** (90%) and Kidney (10%). * **Subcellular sites:** Gluconeogenesis is both mitochondrial and cytosolic, whereas glycolysis is purely cytosolic. * **Energy Requirement:** Gluconeogenesis is an energy-expensive process, requiring **6 ATP/GTP** equivalents to produce one molecule of glucose from two molecules of pyruvate. * **Key Regulatory Enzyme:** Fructose-1,6-bisphosphatase is the most important regulatory site for gluconeogenesis (inhibited by Fructose-2,6-bisphosphate).

Q: Which of the following is a reducing sugar?

Isomaltose. ### Explanation **Concept:** A sugar is classified as **reducing** if it possesses a free (unbound) anomeric carbon atom (aldehyde or ketone group). This allows the sugar to act as a reducing agent in tests like Benedict’s or Fehling’s. In disaccharides, if the glycosidic bond involves the anomeric carbons of both monosaccharides, the sugar becomes **non-reducing**. **Why Isomaltose is Correct:** Isomaltose is a disaccharide composed of two glucose units linked by an **α(1→6) glycosidic bond**. While the anomeric carbon (C1) of the first glucose is occupied in the bond, the anomeric carbon (C1) of the second glucose remains **free**. This free hemiacetal group allows it to reduce cupric ions, making it a reducing sugar. **Why Other Options are Incorrect:** * **Sucrose (Table Sugar):** It is formed by a linkage between the anomeric carbons of both monomers (**α1 → β2** linkage between Glucose and Fructose). Since both reducing groups are locked in the bond, it is a non-reducing sugar. * **Trehalose:** Found in mushrooms and insects, it consists of two glucose units linked by an **α1 → α1** bond. Both anomeric carbons are involved in the glycosidic linkage, making it non-reducing. **High-Yield Clinical Pearls for NEET-PG:** * **All Monosaccharides** (Glucose, Fructose, Galactose) are reducing sugars. * **Common Reducing Disaccharides:** Maltose, Isomaltose, and Lactose (Mnemonic: **MIL**). * **Non-reducing Disaccharides:** Sucrose and Trehalose. * **Clinical Correlation:** The **Benedict’s Test** is used to detect reducing sugars in urine (e.g., Glucosuria in Diabetes Mellitus or Galactosuria in Galactosemia). Sucrose will give a negative Benedict's test unless it is first hydrolyzed by acid.

Question 1

A baby presents with early morning hypoglycemia. Glucagon administration raises blood glucose levels if given after meals but not during fasting. Liver biopsy shows increased glycogen deposits. What enzyme defect is most likely responsible?

Accepted Answer

Debranching enzyme

Answer

Muscle phosphorylase

Answer

Glucose-6-phosphatase

Answer

Branching enzyme

Question 2

Patients with G6PD deficiency often have an increased susceptibility to infection, which in turn may precipitate a hemolytic episode. What is the most likely underlying mechanism for the increased risk of infection?

Accepted Answer

Decreased amount of reduced nicotinamide adenine dinucleotide phosphate (NADPH) in the white blood cells

Answer

Decreased amount of glutathione in the white blood cells

Answer

Defective phagocytosis

Answer

Deficiency of myeloperoxidase

Question 3

A patient's blood glucose levels are normal by the GOD-POD method, but their urine shows a positive Benedict's test. What is the most likely reason for this discrepancy in results?

Accepted Answer

Galactosemia

Answer

False positive result

Answer

Fructosemia

Answer

Glucose intolerance

Question 4

A patient has a rare disease characterized by impaired secretory function of the alpha-cells of the pancreas. Direct stimulation of which of the following pathways in the liver will be impaired?

Accepted Answer

Gluconeogenesis

Answer

Citric acid cycle

Answer

Glycogenesis

Answer

Glycolysis

Question 5

Which of the following enzymes is involved in gluconeogenesis, except?

Accepted Answer

Phosphoglucomutase

Answer

Phosphoglycerate kinase

Answer

Fructose 1, 6-biphosphatase

Answer

Pyruvate carboxylase

Question 6

Which metabolite is involved in glycolysis, the HMP shunt pathway, and gluconeogenesis?

Accepted Answer

Glucose-6-phosphate

Answer

Glucose-1-phosphate

Answer

Fructose-6-phosphate

Answer

Pyruvate

Question 7

What are isomers that differ in the position of -H and -OH at the 2nd, 3rd, and 4th carbon atoms of glucose called?

Accepted Answer

Epimers

Answer

Optical isomers

Answer

Anomers

Answer

D,L isomers

Question 8

Which enzyme of glycolysis is also used in gluconeogenesis?

Accepted Answer

Phosphotriose isomerase

Answer

Glucokinase

Answer

Phosphofructokinase (PFK)

Answer

Pyruvate kinase

Question 9

Which of the following is NOT typically observed in a patient with hereditary fructose intolerance?

Accepted Answer

Elevated fructose and galactose levels in blood after fructose load

Answer

Elevated glucose and fructose levels in blood after fructose load

Answer

Elevated fructose and galactose levels in urine after fructose load

Answer

Elevated fructose and maltose levels in blood after fructose load

Question 10

Which of the following is a reducing sugar?

Accepted Answer

Isomaltose

Answer

Sucrose

Answer

Trehalose

Answer

All of the above

Carbohydrate Metabolism — MCQs

Carbohydrate Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?